966 results on '"Hou, Hsin-An"'
Search Results
2. Type 2 Biomarkers and Their Clinical Implications in Bronchiectasis: A Prospective Cohort Study
3. Early Therapeutic Drug Monitoring Optimizes Teicoplanin Use in Febrile Neutropenic Patients with Hematological Malignancies
4. Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients
5. The clinical impacts of lung microbiome in bronchiectasis with fixed airflow obstruction: a prospective cohort study
6. Healthcare resource utilisation and costs associated with AL amyloidosis: a retrospective matched cohort study
7. Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia
8. Stellae-123 gene expression signature improved risk stratification in Taiwanese acute myeloid leukemia patients
9. Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms
10. Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations
11. Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis
12. Study Protocol of a Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in COVID-19 Patients with Comorbidities
13. Anti-leukemia effects of omipalisib in acute myeloid leukemia: inhibition of PI3K/AKT/mTOR signaling and suppression of mitochondrial biogenesis
14. Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic target
15. Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group
16. Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes
17. Planarized through-hole valves enabling multilayered microfluidic architecture towards pipette-free ELISA
18. Genomic Landscape and Risk Stratification of Acute Myeloid Leukemia
19. Fibroblast growth factor 5 expression predicts the progression of oral squamous cell carcinoma
20. Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial
21. Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification
22. Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML
23. Primary effusion anaplastic large cell lymphoma with indolent clinical course and IRF4/DUSP22 rearrangement: a case report expanding the spectrum of effusion-based lymphoma
24. The clinical and biological characterization of acute myeloid leukemia patients with S100A4 overexpression
25. Epidemiology and survival outcomes of acute myeloid leukemia patients in Taiwan: A national population-based analysis from 2001 to 2015
26. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
27. Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias
28. Clinical relevance of NFYA splice variants in patients with acute myeloid leukaemia undergoing intensive chemotherapy.
29. Iontophoresis-Enhanced Buccal Delivery of Cisplatin-Encapsulated Chitosan Nanoparticles for Treating Oral Cancer in a Mouse Model.
30. Oral Lactobacillus zeae exacerbates the pathological manifestation of periodontitis in a mouse model.
31. Clinical outcomes of intravitreal methotrexate injection protocol with a reduced initial frequency for intraocular lymphoma
32. Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair
33. Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
34. Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
35. Effectiveness of induction regimens on survival outcome in acute myeloid leukemia patients: a real-world data from 2001 to 2015
36. A population-based cohort study of the epidemiology of light-chain amyloidosis in Taiwan
37. Microbiome of periodontitis and peri‐implantitis before and after therapy: Long‐read 16S rRNA gene amplicon sequencing
38. A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes
39. Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
40. Genomic characterization of AML with aberrations of chromosome 7:a multinational cohort of 519 patients
41. Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of FLT3
42. IDH2 mutation accelerates TPO‐induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo.
43. TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype
44. Matrix Metalloprotease-7 Mediates Nucleolar Assembly and Intra-nucleolar Cleaving p53 in Gefitinib-Resistant Cancer Stem Cells
45. Fucosyltransferase 4 shapes oncogenic glycoproteome to drive metastasis of lung adenocarcinoma
46. A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients
47. Titanium Surfaces with a Laser-Produced Microchannel Structure Enhance Pre-Osteoblast Proliferation, Maturation, and Extracellular Mineralization In Vitro
48. Early Therapeutic Drug Monitoring Optimizes Teicoplanin Use in Patients with Hematological Malignancies
49. Baseline Blood Levels of Mucin-1 Are Associated with Crucial On-Treatment Adverse Outcomes in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Pirfenidone
50. An Ensemble Model for Acute Myeloid Leukemia Risk Stratification Recommendations by Combining Machine Learning with Clinical Guidelines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.